Xu-Chao Zhang Selected Research

Carcinoma (Carcinomatosis)

1/2022	PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.
1/2020	Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.
8/2011	Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer.
9/2007	KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu-Chao Zhang Research Topics

Disease

52	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2009
36	Neoplasms (Cancer) 01/2024 - 09/2007
30	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2007
11	Adenocarcinoma of Lung 01/2024 - 01/2012
8	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2017
5	Adenocarcinoma 11/2019 - 05/2010
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2023 - 12/2017
4	Carcinoma (Carcinomatosis) 01/2022 - 09/2007
3	Disease Progression 01/2023 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 07/2014
2	Carcinogenesis 01/2016 - 08/2012
1	Exanthema (Rash) 12/2023
1	Neuroendocrine Carcinoma 09/2023
1	Albuminuria 02/2023
1	Glomerulonephritis 02/2023
1	IGA Glomerulonephritis (IGA Nephropathy) 02/2023
1	Circulating Neoplastic Cells 01/2023
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Malignant Pleural Effusion 01/2022
1	Carcinoid Tumor (Carcinoid) 12/2021
1	Adenocarcinoma in Situ 11/2019
1	Solitary Pulmonary Nodule 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015
1	Lymphatic Metastasis 07/2015
1	Neuroblastoma 07/2014
1	Lymphoma (Lymphomas) 03/2014
1	Neutropenia 06/2012
1	Esophageal Neoplasms (Esophageal Cancer) 01/2012
1	Rare Diseases (Rare Disease) 01/2012

Drug/Important Bio-Agent (IBA)

32	ErbB Receptors (EGF Receptor)IBA 01/2024 - 12/2009
27	Tyrosine Kinase InhibitorsIBA 01/2024 - 12/2009
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2007
10	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
8	Gefitinib (Iressa)FDA Link 11/2021 - 01/2011
7	Anaplastic Lymphoma KinaseIBA 01/2023 - 03/2014
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2011
5	CrizotinibIBA 11/2018 - 03/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2019
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 01/2016
3	Gemcitabine FDA Link 01/2023 - 03/2010
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2007
2	PlatinumIBA 12/2023 - 01/2017
2	pembrolizumabIBA 12/2023 - 01/2021
2	osimertinibIBA 01/2022 - 01/2018
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021 - 07/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020 - 03/2014
2	B7-H1 AntigenIBA 11/2019 - 11/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019 - 12/2014
2	IGF-I-IGFBP-3 complex FDA Link 06/2017 - 03/2016
2	Phosphotransferases (Kinase)IBA 03/2014 - 09/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2011 - 01/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2024
1	sintilimabIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Mutant Proteins (Protein, Mutant)IBA 09/2023
1	Galactose (Galactopyranose)FDA LinkGeneric 02/2023
1	Immunoglobulin A (IgA)IBA 02/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 12/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2021
1	icotinibIBA 12/2021
1	Protons (Proton)IBA 07/2020
1	sotorasibIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	abivertinibIBA 05/2019
1	Complementary DNA (cDNA)IBA 12/2017
1	LigandsIBA 06/2017
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	Adiponectin ReceptorsIBA 07/2015
1	Carcinoembryonic AntigenIBA 07/2015
1	Class Ia Phosphatidylinositol 3-KinaseIBA 07/2014
1	human ERBB2 proteinIBA 07/2014
1	MAP Kinase Kinase 1IBA 07/2014
1	TensinsIBA 07/2014
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2013
1	Everolimus FDA Link 11/2012
1	ORALIT (ORS)IBA 10/2012
1	Extracellular Matrix ProteinsIBA 08/2012
1	KalininIBA 08/2012
1	Bevacizumab (Avastin)FDA Link 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Hemoglobins (Hemoglobin)IBA 06/2012
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 09/2011

Therapy/Procedure

18	Therapeutics 01/2023 - 09/2007
13	Drug Therapy (Chemotherapy) 12/2023 - 03/2010
10	Immunotherapy 01/2024 - 06/2017
3	Precision Medicine 01/2023 - 03/2014
2	Neoadjuvant Therapy 01/2023 - 01/2019
2	Lasers (Laser) 06/2017 - 03/2016
2	Thoracotomy 07/2015 - 05/2010
1	Aftercare (After-Treatment) 01/2021
1	Operative Surgical Procedures 01/2018